ISpecimen Inc

iSpecimen’s new direct‑shipment model cuts biospecimen transit times by up to 85% and drove a 91% surge in its share price.

iSpecimen Inc. reports a sharp 96.6% revenue drop to $0.1M yet improves per‑share loss to $0.74; discover how the tech‑driven marketplace is reshaping specimen sourcing.

iSpecimen Inc. raises $5.5 M in a private placement to expand its tech‑driven specimen marketplace, fueling growth and supporting global medical research.

iSpecimen Inc.

iSpecimen Inc. has established a $200 million Solana-based corporate treasury, marking a significant pivot towards integrating digital assets into its financial operations and potentially opening new avenues for growth and innovation.

iSpecimen Inc.’s stock has plummeted from a 52-week high of $11.80 to $1.13, sparking financial scrutiny and raising concerns about the company’s profitability and market valuation.